Fc®IIA and Fcγ RIIIB polymorphisms in myasthenia gravis

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 173-176

  Raknes, Guttorm ^a   Skeie, Geir Olve ^a   Gilhus, Nils Erik ^a   Aadland, Sissel ^a   Vedeler, Christian ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoantibodies; Autoimmunity; FcR; Myasthenia gravis; Neuroimmunology; Thymoma

Indexed keywords

FC RECEPTOR;

ARTICLE; CLINICAL TRIAL; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; IMMUNOPATHOGENESIS; MYASTHENIA GRAVIS; PHAGOCYTOSIS; PRIORITY JOURNAL; ALLELE; AUTOIMMUNE DISEASE; CLASSIFICATION; DISEASE PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; ONSET AGE; THYMOMA;

AGE OF ONSET; ALLELES; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; GENE FREQUENCY; GENOTYPE; HUMANS; MYASTHENIA GRAVIS; POLYMORPHISM, GENETIC; RECEPTORS, IGG; THYMOMA; THYMUS NEOPLASMS;

EID: 0031594246     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00174-4     Document Type: Article

References (21)

1. Bergoffen J., Zmijewski C.M., Fischbeck K.H. Familial autoimmune myasthenia gravis. Neurology. 44:1994;551-554.
2. Botto M., Theodoridis E.M., Thompson H.L.C., Briggs D., Isenberg D.A., Walport M.J., Davis K.A. FcgRIIA polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin. Exp. Immunol. 104:1996;264-268.
3. Bux J., Stein E.L., Santoso S., Mueller-Eckhardt C. NA gene frequencies in the German population, determined by polymerase chain reaction with sequence-specific primers. Transfusion. 35:1995;54-57.
4. Carlsson B., Wallin J., Pirskanen R., Matell G., Smith C.I.E. Different HLA DR-DQ associations in subgroups of idiopathic myasthena gravis. Immunogenetics. 31:1990;285-290.
5. Gautel M., Lakey A., Barlow P.D., Holmes Z., Scales S., Leonard K., Labeit S., Mygland Å., Gilhus N.E., Aarli J.A. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology. 43:1993;1581-1585.
6. Gilhus N.E., Matre R. Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis. J. Neuroimmunol. 10(3):1986;271-278.
7. Goldblatt D., Scadding G.K., Lund V.J., Wade A.M., Turner M.W., Pandey J.P. Association of Gm Allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J. Immunol. 153:1994;5316-5320.
8. Kimberly R.P., Salmon J.E., Edberg J.C. Receptors for immunoglobulin G. Arthritis and Rheumatism. 38:1995;306-314.
9. Lefvert A.K., Bergstrøm K., Matell G., Osterman P.O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J. Neurol. Neurosurg. Psychiat. 41:1978;394-403.
10. Lynch R.G., Hagen M., Mueller A., Sandor M. Potential role of FcR in the early development of murine lymphoid cells: evidence for functional interaction between FcgR on pre-thymocytes and an alternative, non-Ig ligand on thymic stromal cells. Immunol. Lett. 44:1995;105-109.
11. Marshall B., Leelayuwat C., Abraham L.J., Pinelli M., Dawkins R.L. Large transcripts and sequence from a polymorphic 170 kb MHC region implicated in susceptibility to autoimmune disease. Immunogenetics. 39:1994;15-20.
12. Melms A., Weissert R., Klinkert W.E., Schalke B.C., Tzartos S., Werkerle H. Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation. Neurology. 43:1993;583-588.
13. Mygland Å., Tysnes O.B., Matre R., Volpe P., Aarli J.A., Gilhus N.E. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann. Neurol. 32:1992;589-591.
14. Mygland Å., Tysnes O.B., Aarli J.A., Matre R., Gilhus N.E. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. J. Autoimmunity. 6:1993;507-515.
15. Murphy J., Murphy S.F. Myasthenia gravis in identical twins. Neurology. 36:1986;78-80.
16. Pandey J.P., French A.H. GM phenotypes influence the concentrations of the four subclasses of IgG in normal human serum. Hum. Immunology. 51:1996;99-102.
17. Salmon J.E., Edberg J.C., Kimberly R.P. FcγR on neutrophils: allelic variants have functionally distinct capacities. J. Clin. Invest. 85:1990;1287-1295.
18. Salmon J.E., Millard S.S., Brogle N.L., Kimberly R.P. Fcγ receptor IIIB enhances Fcγ Receptor IIA function in an oxidant-dependent and allele-sensitive manner. J. Clin. Invest. 95:1995;2877-2885.
19. Sanders L.A.M., Feldman R.G., Voorhorst-Ogink M.M., de Haas M., Rijkers G.T., Capel P.J.A., Zegers B.J.M., van de Winkel J.G.J. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 63:1995;73-81.
20. Skeie G.O., Pandey J.P., Aarli J.A., Gilhus N.E. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 26:1997;111-116.
21. Willcox N. Myasthenia gravis. Curr. Opin. Immunol. 5:1993;910-917.